These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 2257776)
1. Contrast sensitivity and the diagnosis dysthyroid optic neuropathy. Mourits MP; Suttorp-Schulten MS; Tijssen RO; Apkarian P Doc Ophthalmol; 1990; 74(4):329-35. PubMed ID: 2257776 [TBL] [Abstract][Full Text] [Related]
2. Contrast sensitivity function in Graves' ophthalmopathy and dysthyroid optic neuropathy. Suttorp-Schulten MS; Tijssen R; Mourits MP; Apkarian P Br J Ophthalmol; 1993 Nov; 77(11):709-12. PubMed ID: 8280684 [TBL] [Abstract][Full Text] [Related]
3. Course of pattern-reversed visual evoked cortical potentials in 30 eyes after bony orbital decompression in dysthyroid optic neuropathy. Lipski A; Eckstein A; Esser J; Loesch C; Mann K; Mohr C; Jurklies B Br J Ophthalmol; 2011 Feb; 95(2):222-6. PubMed ID: 20584712 [TBL] [Abstract][Full Text] [Related]
4. Measuring contrast sensitivity in patients with Graves' ophthalmopathy complicated by ocular hypertension and suspect glaucoma or dysthyroid optic neuropathy. De Marco R; Ambrosio G; Ferrara G Doc Ophthalmol; 2000 Sep; 101(2):165-77. PubMed ID: 11200548 [TBL] [Abstract][Full Text] [Related]
5. Graves' ophthalmopathy: III. Effect of transantral orbital decompression on optic neuropathy. Hallin ES; Feldon SE; Luttrell J Br J Ophthalmol; 1988 Sep; 72(9):683-7. PubMed ID: 3179256 [TBL] [Abstract][Full Text] [Related]
6. Transfrontal orbital decompression after failure of transantral decompression in optic neuropathy of Graves' disease. Fatourechi V; Bartley GB; Garrity JA; Bergstralh EJ; Ebersold MJ; Gorman CA Mayo Clin Proc; 1993 Jun; 68(6):552-5. PubMed ID: 8497132 [TBL] [Abstract][Full Text] [Related]
7. Transcaruncular orbital decompression for dysthyroid optic neuropathy. Perry JD; Kadakia A; Foster JA Ophthalmic Plast Reconstr Surg; 2003 Sep; 19(5):353-8. PubMed ID: 14506419 [TBL] [Abstract][Full Text] [Related]
8. Optic neuropathy of Graves disease: results of transantral orbital decompression and long-term follow-up in 215 patients. Soares-Welch CV; Fatourechi V; Bartley GB; Beatty CW; Gorman CA; Bahn RS; Bergstralh EJ; Schleck CD; Garrity JA Am J Ophthalmol; 2003 Sep; 136(3):433-41. PubMed ID: 12967795 [TBL] [Abstract][Full Text] [Related]
9. Complete recovery of visual acuity as the main goal of treatment in patients with dysthyroid optic neuropathy. Miśkiewicz P; Rutkowska B; Jabłońska A; Krzeski A; Trautsolt-Jeziorska K; Kęcik D; Milczarek-Banach J; Pirko-Kotela K; Samsel A; Bednarczuk T Endokrynol Pol; 2016; 67(2):166-73. PubMed ID: 26884288 [TBL] [Abstract][Full Text] [Related]
10. [Therapeutic outcomes and influence factors of maximal orbital decompression in the treatment of severe dysthyroid optic neuropathy]. Wang Y; Li YY; Yang N; Ma R; Xiao LH Zhonghua Yan Ke Za Zhi; 2017 Jun; 53(6):416-423. PubMed ID: 28606262 [TBL] [Abstract][Full Text] [Related]
11. Surgical Treatment of Dysthyroid Optic Neuropathy: Long-Term Visual Outcomes with Comparison of 2-Wall versus 3-Wall Orbital Decompression. Korkmaz S; Konuk O Curr Eye Res; 2016; 41(2):159-64. PubMed ID: 25835051 [TBL] [Abstract][Full Text] [Related]
12. Visual evoked potentials in patients with Graves' ophthalmopathy complicated by ocular hypertension and suspect glaucoma or dysthyroid optic neuropathy. Ambrosio G; Ferrara G; Vitale R; De Marco R Doc Ophthalmol; 2003 Mar; 106(2):99-104. PubMed ID: 12678273 [TBL] [Abstract][Full Text] [Related]
13. Using frequency-doubling perimetry to detect optic neuropathy in patients with Graves' orbitopathy. Monteiro MLR; Portes ALF; Moura FC; Regensteiner DBW Jpn J Ophthalmol; 2008; 52(6):475-482. PubMed ID: 19089569 [TBL] [Abstract][Full Text] [Related]
14. Results of transmedial-canthal ethmoidal decompression for severe dysthyroid optic neuropathy. Ohtsuka K; Nakamura Y Jpn J Ophthalmol; 1999; 43(5):426-32. PubMed ID: 10580667 [TBL] [Abstract][Full Text] [Related]
15. Clinical features of dysthyroid optic neuropathy: a European Group on Graves' Orbitopathy (EUGOGO) survey. McKeag D; Lane C; Lazarus JH; Baldeschi L; Boboridis K; Dickinson AJ; Hullo AI; Kahaly G; Krassas G; Marcocci C; Marinò M; Mourits MP; Nardi M; Neoh C; Orgiazzi J; Perros P; Pinchera A; Pitz S; Prummel MF; Sartini MS; Wiersinga WM; Br J Ophthalmol; 2007 Apr; 91(4):455-8. PubMed ID: 17035276 [TBL] [Abstract][Full Text] [Related]
17. Contrast sensitivity of thyroid associated ophthalmopathy patients without obvious optic neuropathy. Beden Ü; Kaya S; Yeter V; Erkan D ScientificWorldJournal; 2013; 2013():943789. PubMed ID: 24453927 [TBL] [Abstract][Full Text] [Related]
18. [Visual evoked potentials in diagnosis and monitoring of optic neuropathy in the course of thyroid ophthalmopathy]. Rutecka-Debniak A; Lubiński W; Krzystolik Z Klin Oczna; 1999; 101(5):361-5. PubMed ID: 10714075 [TBL] [Abstract][Full Text] [Related]
19. [Clinical characteristics of dysthyroid optic neuropathy]. Elyashiv S; Skaat A; Ben Simon G; Huna-Baron R Harefuah; 2015 Feb; 154(2):98-102, 137. PubMed ID: 25856861 [TBL] [Abstract][Full Text] [Related]
20. Changes in optical coherence tomography measurements after orbital wall decompression in dysthyroid optic neuropathy. Park KA; Kim YD; Woo KI Eye (Lond); 2018 Jun; 32(6):1123-1129. PubMed ID: 29491488 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]